Biotech · Private company · Boston, MA, US

Elevation Oncology, Inc.

SEC CIK 0001783032

Track this companyFree. Adds Elevation Oncology, Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials40 recruiting or active

Pipeline programs8From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

Pipeline8

DocetaxelPhase 2 · Non-Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
FulvestrantPhase 2 · Metastatic Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
MM-121Phase 2 · Non-Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
SeribantumabPhase 2 · Locally Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
SeribantumabPhase 2 · Metastatic Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
DostarlimabPhase 1 · Stomach NeoplasmClinicalTrials.gov · fetched Nov 12, 2026
EO-3021Phase 1 · Stomach NeoplasmClinicalTrials.gov · fetched Nov 12, 2026
Ramucirumab (CYRAMZA®)Phase 1 · Stomach NeoplasmClinicalTrials.gov · fetched Nov 12, 2026

Study of EO-3021 in Adult Patients With Solid Tumors Likely to Express CLDN18.2PHASE1 · TERMINATED · started Aug 10, 2023ClinicalTrials.gov NCT05980416 · fetched Nov 12, 2026
Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid TumorsPHASE2 · TERMINATED · started Sep 29, 2020ClinicalTrials.gov NCT04383210 · fetched Nov 12, 2026
Phase 2 Trial of Seribantumab Plus Fulvestrant in Postmenopausal Women With Metastatic Breast CancerPHASE2 · TERMINATED · started Aug 15, 2017ClinicalTrials.gov NCT03241810 · fetched Nov 12, 2026
A Study of MM-121 in Combination With Chemotherapy Versus Chemotherapy Alone in Heregulin Positive NSCLCPHASE2 · TERMINATED · started Feb 1, 2015ClinicalTrials.gov NCT02387216 · fetched Nov 12, 2026